Search - tctmd.com

Displaying 1 - 20 of 75

Sort: Relevancy | Date

News Daily News

Radial Artery Best for Secondary Access During TAVI: PULSE Registry

Michael O'Riordan

December 23, 2024

Sustained Benefit With Pascal TEER Device at 2 Years: CLASP IID and MiCLASP

Michael O'Riordan

December 05, 2024

News Conference News PCR London Valves 2024

Reverse Remodeling and Higher Stroke Volume With TEER: TRILUMINATE

Michael O'Riordan

December 03, 2024

News Conference News PCR London Valves 2024

Electrical Variables, Not Valve Type, Predict Need for Pacemaker After TAVI

Michael O'Riordan

December 02, 2024

News Conference News PCR London Valves 2024

Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years

Michael O'Riordan

November 27, 2024

News Conference News PCR London Valves 2024

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

Michael O'Riordan

November 26, 2024

News Conference News PCR London Valves 2024

Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia

Michael O'Riordan

November 26, 2024

News Conference News PCR London Valves 2024

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Michael O'Riordan

November 25, 2024

News Conference News TCT 2024

Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI

Michael O'Riordan

November 06, 2024

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

News Conference News TCT 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

Todd Neale

October 30, 2024

Presentation TCT 2024

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Presenter: Michael Reardon

October 30, 2024

Presentation TCT 2024

TCT 918: Association of TVT Site Risk Adjusted Stroke Rates and Joint Commission Stroke Certification Designation Level

Presenter: G. Michael Deeb

October 30, 2024

Presentation TCT 2024

COUNTERPOINT: The Surgical Standard Will Predominate!

Presenter: Michael Bowdish

October 30, 2024

News Conference News TCT 2024

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

Michael O'Riordan

October 29, 2024

Presentation TCT 2024

Between Pressure and Volume: Right Heart Physiology in TR

Presenter: Michael Brener

October 29, 2024

Presentation TCT 2024

TCT 1419: Ascending Aortic Pseudoaneurysm Seven Years After TAVR and Seventeen Years After SAVR

Presenter: Michael Morgan

October 29, 2024

Presentation TCT 2024

Case 3: TR in the Setting of Advanced LV Dysfunction – Finding the Sweet Spot

Presenter: Michael Brener

October 29, 2024

Presentation TCT 2024

Case-Based Examples – Primary MR, Green Zone Anatomy (Including Optimizing the Transseptal Puncture)

Presenter: Michael Young

October 29, 2024

News Conference News TCT 2024

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

Michael O'Riordan

October 28, 2024

Advertisement

Radial Artery Best for Secondary Access During TAVI: PULSE Registry

Sustained Benefit With Pascal TEER Device at 2 Years: CLASP IID and MiCLASP

Reverse Remodeling and Higher Stroke Volume With TEER: TRILUMINATE

Electrical Variables, Not Valve Type, Predict Need for Pacemaker After TAVI

Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

TCT 918: Association of TVT Site Risk Adjusted Stroke Rates and Joint Commission Stroke Certification Designation Level

COUNTERPOINT: The Surgical Standard Will Predominate!

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

Between Pressure and Volume: Right Heart Physiology in TR

TCT 1419: Ascending Aortic Pseudoaneurysm Seven Years After TAVR and Seventeen Years After SAVR

Case 3: TR in the Setting of Advanced LV Dysfunction – Finding the Sweet Spot

Case-Based Examples – Primary MR, Green Zone Anatomy (Including Optimizing the Transseptal Puncture)

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content